Canada Pension Plan Investment Board’s Collegium Pharmaceutical COLL Stock Holding History

Canada Pension Plan Investment Board’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$720K	Sell	19,900 -1,400	-7%	-$47.8K	﹤0.01%	1122
2026 Q1	$704K	Sell	21,300 -5,600	-21%	-$237K	﹤0.01%	1107
2025 Q4	$1.25M	Buy	26,900 +23,800	+768%	+$996K	﹤0.01%	1019
2025 Q3	$108K	Buy	+3,100	New	+$108K	﹤0.01%	1186
2024 Q2	–	Sell	-37,566	Closed	-$1.46M	–	1387
2024 Q1	$1.46M	Buy	+37,566	New	+$1.31M	﹤0.01%	952

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Canada Pension Plan Investment Board's COLL Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Collegium Pharmaceutical (COLL) stake by 6.6% in Q2 2026, selling an estimated $47.8K and leaving 19,900 shares worth $720K. The position accounts for ﹤0.01% of the portfolio, ranked #1122.

Canada Pension Plan Investment Board first reported a position in COLL in Q1 2024 and has held it in 5 quarters since. The position peaked at $1.46M in Q1 2024. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Canada Pension Plan Investment Board held 19,900 shares of Collegium Pharmaceutical worth $720K as of Q2 2026.
Canada Pension Plan Investment Board sold 1,400 Collegium Pharmaceutical shares in Q2 2026, an estimated $47.8K.
Collegium Pharmaceutical made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #1122 holding.
Canada Pension Plan Investment Board first reported a position in Collegium Pharmaceutical in Q1 2024 and has held it in 5 quarters since.
Canada Pension Plan Investment Board's Collegium Pharmaceutical position peaked at $1.46M in Q1 2024.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.